TCL Archive Letter to the Editor: NCI Should Continue Supporting Research In Special Populations July 31, 1998
TCL Archive Kansas Cancer Institute gets $15 million pledge, is renamed, and hires a new director in effort to win NCI center grant. April 16, 2004
TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer March 26, 2010